News for hackers. Stuff that matters.

KhayriRRW

KhayriRRW on Hacker News

Re:Improve Your Privacy in the Age of Mass Surveillance on Saturday June 02, 2018 @09:05AM (#17214405)
Using pseudonyms and sockpuppets will highly probably get them all locked out and suspended by social networks and internet services that have built strong countermeasures against it.

~ Khayri R.R. Woulfe

Re:Facebook losing out to YouTube, Instagram, and Snapchat among US teens on Saturday June 02, 2018 @09:01AM (#17214382)
Facebook puts a lot of restrictions yet ironically the abusive users aren't restricted per se.

~ Khayri R.R. Woulfe

Re:Snapping a photo impairs our ability to remember the subject on Saturday June 02, 2018 @08:58AM (#17214370)
Aren't photographs used to visually remember its subjects in the first place?

~ Khayri R.R. Woulfe

Re:Is the Library Card Dying? (2016) on Saturday June 02, 2018 @08:49AM (#17214336)
Killed by OPAC.

~ Khayri R.R. Woulfe

Re:The Never-Ending War on Fake Reviews on Friday June 01, 2018 @11:19AM (#17206101)
So it has been sustained that the criticism is pointless.

The excuse is also pretty lame. Judging by your profile, your account is new (less than 50 days old) and the Guideline you're referring to is wayback to 2016. There seems to be an inconsistency there. Whether you have older account or not, there is still a clear intention od flaming here. Using a two-year old archive of the guideline is pointless to justify your behavior. New accounts will naturally folllow the latest version of the Guidelines so again it is pointless to refer to old version of the Guidelines.

It is imprudent that you never tried to re-read the Guidelines since 2016, and that would be impossible either because any update to the site, it turned out, is properly published as a news in the front page.

So, again, the elements of trolling, flaming, pointlessness and dishonesty has been sustained.

I perceive this incident as an instance of how old users game the HN system by trolling new users using provocative behavior, virtue signalling and downvoting comments.

But I guess the problem lies in how HN fringe perceives "civility" and "diplomacy" which is at the level of a crude AI that doesn't get past beyond mere keyword bypasses and bowdlerizing techniques. Humans thinking and acting like machines.

~ Khayri R.R. Woulfe

Re:Ask HN: How would you target people on Facebook who are admins of l... on Friday June 01, 2018 @08:09AM (#17204521)
The older the account, the higher the probability that the account manages a page with 50k+ likes.

~ Khayri R.R. Woulfe

Re:Nearly eight in ten of all suicides are male – a figure that has be... on Friday June 01, 2018 @07:27AM (#17204329)
Probably related to studies claiming the Y-Chromosome (what makes males, males) is disappearing: http://theconversation.com/the-y-chromosome-is-disappearing-...

~ Khayri R.R. Woulfe

Re:The Never-Ending War on Fake Reviews on Friday June 01, 2018 @06:55AM (#17204203)
And you have good diplomacy skills? He's clearly flaming pointlessly about my signature. Why was my signature a big deal in the first place? Just grow the eff up and stop minding too much about trivial things. You're wasting too much energy criticizing about non-issues. Just because you write it that you don't mean to be a jerk doesn't mean you do, it's just a way to bowdlerize your harshness and attempt to sound civil while actually being pointless in your criticism, which is otherwise called trolling. Calling a spade a spade or plainspeaking is in no way undiplomatic. I just do not sugarcoat it unlike you who try to be pointlessly hypercritical.

// Contacting the mods via email to take a look at this issue.

~ Khayri R.R. Woulfe

Re:Ask HN: Should I stay on my personal GitHub account or move it to a... on Friday June 01, 2018 @12:40AM (#17202627)
It is better to stick to your personal account instead of creating bogus organizations. You can start an org once you gathered dedicated contributors to the project.

~ Khayri R.R. Woulfe

Re:The Never-Ending War on Fake Reviews on Friday June 01, 2018 @12:31AM (#17202571)
You're pointless and my signature is none of your business. You're a jerk and a troll as well. https://news.ycombinator.com/newsguidelines.html

~ Khayri R.R. Woulfe

Re:The Never-Ending War on Fake Reviews on Thursday May 31, 2018 @11:57PM (#17202463)
Facebook page reviews is a good example of this.

~ Khayri R.R. Woulfe

Re:Logo design trends of 2018 on Thursday May 31, 2018 @11:55PM (#17202458)
Minimalist design is overrated.

~ Khayri R.R. Woulfe

Re:America’s Teens Are Choosing YouTube Over Facebook on Thursday May 31, 2018 @11:52PM (#17202449)
YouTube and Google has better regulations against cyberbullying compared to Facebook.

~ Khayri R.R. Woulfe

Re:Show HN: A Twitter bot that uses computer vision to caption random ... on Thursday May 31, 2018 @09:12AM (#17195989)
This would make for a good IFTTT applet.

~ Khayri R.R. Woulfe

Re:Why doesn't HN use responsive units? on Tuesday May 29, 2018 @08:05AM (#17178326)
Alternatively, you can also use UserJS to modify the font size and layout of HN on your browser.

~ Khayri R.R. Woulfe

Re:World’s First Dengue Vaccine Originated from SLU Research on Sunday February 11, 2018 @04:45AM (#16351989)
A vaccine to prevent dengue fever discovered by a Saint Louis University researcher in 1997 and now licensed worldwide by Sanofi Pasteur has been approved for use in Mexico. Dengvaxia® is the world's first vaccine approved to prevent dengue fever, which is a virus spread by mosquitoes primarily in tropical and sub-tropical areas.

"Dengue fever is a huge costly and debilitating health problem in virtually all developing countries. It is very painful, puts people in the hospital and takes a major toll on the health of children," said Graeme Thomas, director of the office of technology transfer at Saint Louis University.

"SLU is a leader in the field of vaccine development and we're proud to play a role in efforts to prevent human suffering and disease."

SLU is a leader in the field of vaccine development and we're proud to play a role in efforts to prevent human suffering and disease. According to the World Health Organization, about half of the world's population is at risk of developing dengue fever, which is a growing health threat. Dengue is believed to be under-reported, with an estimated 390 million infections a year. With symptoms similar to influenza, dengue affects babies, young children and adults. A rare and severe form of dengue can be deadly, causing extensive bleeding under the skin and inside the body.

Saint Louis University holds the patent on the vaccine, which was developed in 1997 by Thomas Chambers, M.D., then an associate professor of molecular microbiology and immunology. While at SLU, Chambers studied flaviviruses, which typically are spread by mosquitoes in hot, rainy climates. He has subsequently pursued a career in private industry.

A biopharmaceutical company that became Acambis Inc. obtained rights for vaccines developed at SLU to prevent dengue, Japanese encephalitis and West Nile. Acambis later partnered with Sanofi Pasteur to conduct human clinical trials of the vaccine in Asia, Africa and Latin America. Acambis was acquired by Sanofi in 2008.

While Mexico is the first country to approve the use of the dengue vaccine, regulatory boards in other countries where dengue fever is endemic are reviewing licensing the vaccine. In a press release, Sanofi said it has produced first doses of the vaccine. When operating at full production capacity, Sanofi expects to produce 100 million vaccine doses a year.